Genzyme General Takes a Dive

Disney finishes lower; Boston Scientific starts new drug study; plus more of today's stocks in the news

Bear Stearns downgraded Synaptics (SYNA ) to neutral from attractive.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.